PMD News and Press, Psychemedics Corporation From 04/29/20

ACTON, Mass., April 29, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD ), the world leader and pioneer in detecting drugs of abuse using hair analysis, today introduced the first FDA-cleared hair test for cotinine, the predominant metabolite for nicotine.  This test p...

ACTON, Mass., April 28, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) will hold its Annual Meeting of Stockholders (“Annual Meeting”) on Thursday, May 14, 2020 at 2:00 p.m. ET. The meeting, which will be held in a virtual format only, will be webcast to the p...

ACTON, Mass., Feb. 11, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced fourth quarter and year-end financial results for the period ended December 31, 2019.  The Company also announced a quarterly dividend of $0.18 per share payable to shareholders of rec...

ACTON, Mass., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today issued a response to a Massachusetts Supreme Judicial Court ruling in the case of Boston Police Department v. The Massachusetts Civil Service Commission, which dealt with the Boston Police Departme...

Psychemedics (NASDAQ: PMD ): Q3 GAAP EPS of $0.12. More news on: Psychemedics Corporation, Earnings news and commentary, Healthcare stocks news, , Read more ...

ACTON, Mass., Oct. 22, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced third quarter financial results for the period ended September 30, 2019.  The Company also announced a quarterly dividend of $0.18 per share payable to shareholders of record as of Nov...

ACTON, Mass., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (Nasdaq:PMD) announced today that it has entered into a new distribution agreement in Brazil with Sansão Holding S.A. and with Toxicologia Pardini Ltda., our existing independent distributor in Brazil, formerly k...

Psychemedics (NASDAQ: PMD ): Q2 GAAP EPS of $0.14. More news on: Psychemedics Corporation, Earnings news and commentary, Healthcare stocks news, , Read more ...

ACTON, Mass., July 23, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced second quarter financial results for the period ended June 30, 2019.  The Company also announced a quarterly dividend of $0.18 per share payable to shareholders of record as of August ...

Psychemedics ( PMD ) focuses on its patented hair-based drug-testing system. The drug and alcohol testing market is a $6 billion market that is expected to grow at a high single-digit rate in the coming years. The two general macro drivers behind the expectation include stricter legal environm...